Rapid Micro BiosystemsRPID +1.19%60 PB Ratio is 3.79 as of Jun. 26, 2026, which is 405% above its 10-year median of 0.75. GuruFocus rates RPID with a GF Score™ of 60/100 and a GF Value™ of $1.88 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 788 Medical Devices & Instruments companies, Rapid Micro Biosystems ranks worse than 72.21% on this metric.
The historical rank and industry rank for Rapid Micro Biosystems's PB Ratio or its related term are showing as below:
RPID'
s PB Ratio Range Over the Past 10 Years
Min: 0.25 Med: 0.75 Max: 5.93
Current: 3.78
During the past 7 years, Rapid Micro Biosystems's highest PB Ratio was 5.93. The lowest was 0.25. And the median was 0.75.
RPID's PB Ratio is ranked worse than 72.21% of 788
companies
in the Medical Devices & Instruments industry
Industry Median: 2.045
vs RPID: 3.78
During the past 12 months, Rapid Micro Biosystems's average Book Value Per Share Growth Rate was -70.20% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -42.40% per year.
During the past 7 years, the highest 3-Year average Book Value Per Share Growth Rate of Rapid Micro Biosystems was -31.00% per year. The lowest was -42.40% per year. And the median was -36.70% per year.
Back to Basics: PB Ratio
Rapid Micro Biosystems (NAS:RPID) PB Ratio Explanation
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Rapid Micro Biosystems's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Rapid Micro Biosystems PB Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Rapid Micro Biosystems's PB Ratio distribution charts can be found below:
* The bar in red indicates where Rapid Micro Biosystems's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Rapid Micro Biosystems (RPID) has a PB Ratio of 3.79 as of Jun. 26, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Rapid Micro Biosystems and its competitors. This is 405% above median its historical median of 0.75. Over the past decade, Rapid Micro Biosystems' PB Ratio has ranged from 0.25 to 5.93. According to the industry distribution chart, Rapid Micro Biosystems ranks #569 out of 788 companies in the Medical Devices & Instruments industry, placing it in the top 72.2%.
Is Rapid Micro Biosystems' PB Ratio too high?
Rapid Micro Biosystems' current PB Ratio of 3.79 is 405% above median its 10-year median of 0.75. Over the past 10 years, this metric has ranged from a low of 0.25 to a high of 5.93. The Medical Devices & Instruments industry median PB Ratio is 2.05. Rapid Micro Biosystems' value of 3.79 is 85.3% above this industry median. Based on the distribution chart, Rapid Micro Biosystems ranks #569 out of 788 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Rapid Micro Biosystems has a GF Score™ of 60/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Rapid Micro Biosystems' PB Ratio compare to ZOMDF and STIM?
According to the Medical Devices & Instruments industry distribution chart, Rapid Micro Biosystems ranks #569 out of 788 companies for PB Ratio. This places Rapid Micro Biosystems in the lower half of its industry. The industry median PB Ratio is 2.05. Rapid Micro Biosystems' value of 3.79 is 85.3% above this benchmark. Historically, Rapid Micro Biosystems' own PB Ratio has ranged from 0.25 to 5.93 over the past decade. While the company's 10-year median is 0.75 vs. the industry median of 2.05, Rapid Micro Biosystems has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Devices & Instruments company?
The median PB Ratio among Medical Devices & Instruments companies is 2.05, based on 788 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Rapid Micro Biosystems's current PB Ratio of 3.79 is 85.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Rapid Micro Biosystems and its competitors. For the Medical Devices & Instruments industry, the median PB Ratio is 2.05 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Rapid Micro Biosystems's current PB Ratio is 3.79, which is 405% above median its own 10-year median of 0.75. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rapid Micro Biosystems stock overvalued right now?
Based on GuruFocus' analysis, Rapid Micro Biosystems (RPID) is currently considered Modestly Undervalued. The stock's GF Value™ is $1.88, compared to a current price of $1.69 — trading 10.1% below its estimated fair value. The current PB Ratio is 3.79, which is 405% above median its 10-year median of 0.75 and 85.3% above the Medical Devices & Instruments industry median of 2.05. Rapid Micro Biosystems' overall GF Score™ is 60/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Rapid Micro Biosystems (RPID), the current PB Ratio is 3.79 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Rapid Micro Biosystems (RPID) Overvalued in 2026?
Based on GuruFocus' analysis, Rapid Micro Biosystems stock appears to be undervalued.
The current stock price of $1.69 is trading 10.1% below its estimated GF Value™ of $1.88.
GuruFocus considers Rapid Micro Biosystems to be Modestly Undervalued.
Key valuation signals for RPID:
PB Ratio: 3.79 (405% above median its 10-year median of 0.75)
GF Value™: $1.88 vs. price of $1.69 (10.1% below fair value)
Industry Position: 85.3% above the Medical Devices & Instruments median (#569 of 788)
No single metric tells the full story. See the RPID stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Rapid Micro Biosystems Inc is a life sciences technology company. Its technology uses a sensitive camera and the natural autofluorescence of living cells to identify and quantify microbial growth faster and more accurately than the traditional method, which relies on the human eye. The company develops, manufactures, markets, and sells Growth Direct systems (Systems), proprietary consumables, laboratory information management system (LIMS) connection, and other software and services to address rapid microbial analysis used for quality control in the manufacture of pharmaceuticals, medical devices, and personal care products. Geographically, it generates maximum revenue from the United States, and the rest from Switzerland, Germany, Japan, and all other countries.
60GF Score
Get the complete analysis for RPID
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
RPID has been successfully added to your 
